Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
316
self-reported band not used
Founded
2014
12 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
1
Grant · Nov 2023 · US$ 1.8M
Company type
Partnership
self-reported
Description
Finding solutions to prevent, treat and cure infectious diseases and understanding the complexities of microbes and the immune system requires innovative approaches and concentrated effort. This is why The University of Melbourne – a world leader in education, teaching and research excellence – and The Royal Melbourne Hospital – an internationally renowned institution providing outstanding care, research and learning –partnered to create the Peter Doherty Institute for Infection and Immunity (Doherty Institute); a centre of excellence where leading scientists and clinicians collaborate to improve human health globally.
Located in the heart of Melbourne’s Biomedical Precinct, the Doherty Institute is named in honour of Patron, Laureate Professor Peter Doherty, winner of the 1996 Nobel Prize in Physiology or Medicine for discovering how the immune system recognises virus-infected cells. Under the expert guidance of Director, University of Melbourne Professor Sharon Lewin, a leader in research and clinical management of HIV and infectious diseases, the Doherty Institute has more than 700 staff who work on infection and immunity through a broad spectrum of activities. This includes discovery research; diagnosis, surveillance and investigation of infectious disease outbreaks; and the development of ways to prevent, treat and eliminate infectious diseases.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AU792 Elizabeth Street; Melbourne, VIC 3000Primary
Grid intelligence Members
Funding
Rounds1
Round typeGrant · non-equity funding
Amount (USD)1,800,000
Stage rank1
Investors named1
Since last round2 yr 2 mo
Funding
Show as table · 1 funding round
| Rounds | 1 |
|---|---|
| Axis | 2014 to 2026 |
| Grant · 3 Nov 2023 | US$ 1.8M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
How many people work at this brand?
The record holds 316 counted staff profiles at January 2026. Its self-reported band sits above that count and is not published as a headcount.
Where does The Peter Doherty Institute for Infection and Immunity have offices?
One address on record, Australia only. Primary: 792 Elizabeth Street, Melbourne, VIC 3000.
Has The Peter Doherty Institute for Infection and Immunity raised funding?
One round. Latest 3 November 2023: grant, US$1,800,000, investor CARB-X.
Which companies are listed alongside this brand?
Eight peer profiles on record: Hudson Institute of Medical Research and Burnet Institute.